secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0001193125-23-022827
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics announces $100M follow-on public offering of 14.3M shares at $7.00/share
--------------------------------------------------------------------------------

- Underwriting agreement signed for 14,285,715 shares of Class A common stock at $7.00 per share.
- Gross proceeds of approximately $100 million before underwriting discounts and offering expenses.
- Closing expected February 6, 2023; underwriters have 30-day option for 2,142,857 additional shares.
- Lead underwriters: J.P. Morgan, Cowen, and Evercore.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312523022827/0001193125-23-022827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312523022827/d456639d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-022827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer